• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS ATELLICA IM TOTAL HCG; THCG ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS ATELLICA IM TOTAL HCG; THCG ASSAY Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/11/2022
Event Type  malfunction  
Event Description
The customer observed an initial depressed patient sample result measured on the atellica im 1600 total hcg (thcg) assay, that was discordant with the repeat results from the same sample when remeasured on an alternate atellica im analyzer.The result was reported to the physician who did not question the result.There are no allegations of patient harm, changes in treatment, or delays in diagnosis in association with the discordant atellica im thcg result.
 
Manufacturer Narrative
An outside the united states customer observed an initial depressed patient sample result measured on the atellica im 1600 total hcg(thcg) assay, that was discordant with the repeat results from the same sample when remeasured on an alternate atellica im analyzer.Three levels of quality control biorad - liquichek immunoassay plus control - lot 85300, were processed and their results were within the limits of laboratory acceptance.Routine samples were processed in the same pack.No issues were observed with the reagent pack or pre-analytical handling.The interpretation of results section of the atellica im thcg instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens continues to investigate.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2022-00258 on aug 30, 2022.Additional information - sep 08, 2022 and sep 28, 2022 an outside the united states customer reported a discordant patient result on atellica im 1600 total hcg (thcg) reagent, lot 338.On aug 11, 2022, the patient sample was initially tested on atellica im sn# (b)(6) with a thcg result of 2.7 miu/ml.The same sample was repeated on two other atellica im analyzers and the thcg results were 5.2 and 5.15 miu/ml.All results are clinically negative but the difference between the initial vs.Repeat results is outside the laboratory's acceptance limit.Biorad qc lot 85300 recovered within range on the day of this event.The customer stated that there were no issues identified in the review of thcg level 1 qc performance on atellica im 1600 sn# (b)(6).This issue appears to have been isolated to just the one sample (sid (b)(6).Quality control was in range and no issues were noted with other patient samples indicating that the instrument and reagents were performing acceptably.Level 1 mean= 9.052 sd= 0.60 cv= 6.64%; level 2 mean= 26.7 sd= 2.36 cv= 8.83%; level 3 mean= 411.2 sd= 42.8 cv= 10.4%; while there is insufficient information to determine the cause of this single discordant thcg patient result, siemens cannot rule out pre-analytical factors or a sample handling issue.The customer is operational.No non-conformance product issue was identified.Update to section d4: the expiration date of the product did not appear in the initial mdr.The expiration date sep 12, 2022 has been added to section d4.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM TOTAL HCG
Type of Device
THCG ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key15321948
MDR Text Key301077680
Report Number1219913-2022-00258
Device Sequence Number1
Product Code JHI
UDI-Device Identifier00630414006703
UDI-Public00630414006703
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K172322
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/12/2022
Device Model NumberN/A
Device Catalogue Number10995689
Device Lot Number338
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/15/2022
Initial Date FDA Received08/30/2022
Supplement Dates Manufacturer Received09/08/2022
Supplement Dates FDA Received09/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/12/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age21 YR
Patient SexFemale
-
-